CLOSTRIDOIDES DIFFICILE ASSOCIATED DISEASE
Clinical trials for CLOSTRIDOIDES DIFFICILE ASSOCIATED DISEASE explained in plain language.
Never miss a new study
Get alerted when new CLOSTRIDOIDES DIFFICILE ASSOCIATED DISEASE trials appear
Sign up with your email to follow new studies for CLOSTRIDOIDES DIFFICILE ASSOCIATED DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Pfizer launches massive trial of c. diff vaccine for seniors
⭐️ VACCINE ⭐️ Recruiting nowThis study tests whether a vaccine can prevent C. difficile infection in adults 65 and older. About 32,000 participants will receive either the vaccine or a placebo shot. The study will track infections and side effects over up to three and a half years.
Matched conditions: CLOSTRIDOIDES DIFFICILE ASSOCIATED DISEASE
Phase: PHASE3 • Sponsor: Pfizer • Aim: ⭐️ VACCINE ⭐️
Last updated Aug 16, 2026 00:00 UTC
-
Can a common antibiotic stop c. diff from coming back?
Disease control Recruiting nowThis study tests whether taking oral vancomycin while on other antibiotics can prevent a repeat Clostridioides difficile infection (CDI) in people who had one in the last 120 days. Researchers will compare vancomycin to a placebo in 300 adults. Participants take the study drug tw…
Matched conditions: CLOSTRIDOIDES DIFFICILE ASSOCIATED DISEASE
Phase: PHASE2, PHASE3 • Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC